Michele Loizzi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Michele Loizzi has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
C Lopez
6 shared publications- Angela De Palma
Section of Thoracic Surgery, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari “Aldo Moro”, 70124 Bari, Italy
5 shared publications A Lacitignola
4 shared publicationsF Sollitto
4 shared publications- Francesco Sollitto
Institute of Thoracic Surgery, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy
4 shared publications P Sardelli
4 shared publications
Latest Publications
- 1 November 2017
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 12 (11) , S2199-S2200
P2.17-002 Pulmonary and Mediastinal Paragangliomas: Rare Endothoracic Malignancies with Challenging Diagnosis and Treatment
- 1 November 2017
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 12 (11) , S2199-S2200
P2.17-002 Pulmonary and Mediastinal Paragangliomas: Rare Endothoracic Malignancies with Challenging Diagnosis and Treatment
- 1 December 2013
- Vol. 68 (6) , 559-67
Efficacy and safety of fibrin sealant patch in the treatment of air leakage in thoracic surgery.
Air leakage represents a major problem in lung surgery. Absorbable fibrin sealant patch (AFSP), a collagen sponge coated with human fibrinogen and thrombin, can be used as an adjunct to primary stapling or suturing. This study compared the efficacy of AFSP with manual suturing after primary stapling. This was a prospective, multicenter, randomized study. Patients undergoing lobectomy, bilobectomy, anatomical segmentectomy for lung cancer or wedge resection for pulmonary metastasis with air leakage grade 1 or 2 according to Macchiarini scale after stapler suture were randomized to receive AFSP or standard surgical treatment (ST). The primary endpoint was the reduction of intraoperative air leakage intensity. Duration of postoperative air leakage and number of days until removal of last chest drain were secondary endpoints. Safety was recorded for all patients. A total of 346 patients were enrolled in 14 centres, 179 of whom received AFSP and 167 ST. Intraoperative air leak intensity was reduced in 90.5% of AFSP patients and 82% of ST patients (P=0.03). A significant reduction in postoperative air leakage duration was observed in the AFSP group (P=0.0437). The median number of days until removal of last drainage was 6 (3-37) in the AFSP group and 7 (2-27) in the ST (P=0.38). Occurrence of adverse events was comparable in both groups. AFSP was more efficacious than standard ST as an adjunct to primary stapling in reducing intraoperative air leakage intensity and duration of postoperative air leakage in patients undergoing pulmonary surgery. AFSP was well tolerated.
- 1 December 2013
- Vol. 68 (6) , 559-67
Efficacy and safety of fibrin sealant patch in the treatment of air leakage in thoracic surgery.
Air leakage represents a major problem in lung surgery. Absorbable fibrin sealant patch (AFSP), a collagen sponge coated with human fibrinogen and thrombin, can be used as an adjunct to primary stapling or suturing. This study compared the efficacy of AFSP with manual suturing after primary stapling. This was a prospective, multicenter, randomized study. Patients undergoing lobectomy, bilobectomy, anatomical segmentectomy for lung cancer or wedge resection for pulmonary metastasis with air leakage grade 1 or 2 according to Macchiarini scale after stapler suture were randomized to receive AFSP or standard surgical treatment (ST). The primary endpoint was the reduction of intraoperative air leakage intensity. Duration of postoperative air leakage and number of days until removal of last chest drain were secondary endpoints. Safety was recorded for all patients. A total of 346 patients were enrolled in 14 centres, 179 of whom received AFSP and 167 ST. Intraoperative air leak intensity was reduced in 90.5% of AFSP patients and 82% of ST patients (P=0.03). A significant reduction in postoperative air leakage duration was observed in the AFSP group (P=0.0437). The median number of days until removal of last drainage was 6 (3-37) in the AFSP group and 7 (2-27) in the ST (P=0.38). Occurrence of adverse events was comparable in both groups. AFSP was more efficacious than standard ST as an adjunct to primary stapling in reducing intraoperative air leakage intensity and duration of postoperative air leakage in patients undergoing pulmonary surgery. AFSP was well tolerated.
- Open Access
- 18 September 2013
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 17 (suppl 2) , S89
083 * PROGNOSTIC FACTORS AND CLINICAL OUTCOME OF PATIENTS WITH PERIPHERAL N0 ADENOCARCINOMA
Objectives: Many reports emphasize the role of sublobar resections in the treatment of small peripheral lung cancer. The aim of this study is to investigate a range of prognostic factors, including the extension of resection, which may affect the prognosis in a homogeneous group of patients. Methods: We retrospectively reviewed the clinical records of 279 patients affected by N0 small peripheral adenocarcinoma (ADK) smaller than 3 cm who underwent surgery between 2000 and 2010. Eleven patients were excluded for non-tumour-related death. There were 176 (66%) males and 93 (34%) females with a median age of 74 (range 47-93) years. Results: In the series, 229 (85%) patients received a lobar resection and only 39 (15%) a sublobar resection. One-hundred and ninety-five patients (72%) were stage IA while 73 (28%) were stage IB. No differences in 5-year survival were observed according to age (P = 0.32), sex (P = 0.42), T1a vs T1b (P = 0.31), stage IA vs IB (P = 0.51) and type of resection (P = 0.29). Patients affected by ADK with a predominant lepidic growth showed a better 5-year survival (91.3% vs 81.5%, P = 0.044). In patients with stage IB, the sublobar resection was associated with a significantly lower 5-year survival compared with lobectomy (63% vs 90%, P = 0.03). The visceral pleural infiltration was independent from ADK growth pattern, predominant lepidic vs not lepidic (P = 0.51), but it was significantly most frequent in ADK bigger than 2 cm (P = 0.012). Conclusions: Small peripheral N0 lung ADK can be easily resected by wedge or anatomical segmentectomy. However, in case of visceral pleural infiltration, lobectomy significantly reduces the risk of recurrence.
- 18 September 2013
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 17 (suppl 2) , S89
Open Access083 * PROGNOSTIC FACTORS AND CLINICAL OUTCOME OF PATIENTS WITH PERIPHERAL N0 ADENOCARCINOMA
Objectives: Many reports emphasize the role of sublobar resections in the treatment of small peripheral lung cancer. The aim of this study is to investigate a range of prognostic factors, including the extension of resection, which may affect the prognosis in a homogeneous group of patients. Methods: We retrospectively reviewed the clinical records of 279 patients affected by N0 small peripheral adenocarcinoma (ADK) smaller than 3 cm who underwent surgery between 2000 and 2010. Eleven patients were excluded for non-tumour-related death. There were 176 (66%) males and 93 (34%) females with a median age of 74 (range 47-93) years. Results: In the series, 229 (85%) patients received a lobar resection and only 39 (15%) a sublobar resection. One-hundred and ninety-five patients (72%) were stage IA while 73 (28%) were stage IB. No differences in 5-year survival were observed according to age (P = 0.32), sex (P = 0.42), T1a vs T1b (P = 0.31), stage IA vs IB (P = 0.51) and type of resection (P = 0.29). Patients affected by ADK with a predominant lepidic growth showed a better 5-year survival (91.3% vs 81.5%, P = 0.044). In patients with stage IB, the sublobar resection was associated with a significantly lower 5-year survival compared with lobectomy (63% vs 90%, P = 0.03). The visceral pleural infiltration was independent from ADK growth pattern, predominant lepidic vs not lepidic (P = 0.51), but it was significantly most frequent in ADK bigger than 2 cm (P = 0.012). Conclusions: Small peripheral N0 lung ADK can be easily resected by wedge or anatomical segmentectomy. However, in case of visceral pleural infiltration, lobectomy significantly reduces the risk of recurrence.
- Open Access
- 8 October 2012
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 43 (1) , 187-189
Propranolol as first-line treatment of a severe subglottic haemangioma
Subglottic haemangioma (SGH) is a rare, benign tumour in children, which is potentially life-threatening because of airway obstruction. We report the case of a full-term 2-month-old infant girl admitted to our institution with stridor, dyspnoea and oxygen desaturation caused by a SGH and treated with propranolol. Neck-chest computed tomography (CT) revealed a contrast-enhancing, 10-mm, subglottic elliptic lesion, referable to SGH. Pre-treatment fibrobronchoscopy showed a sub-occlusive SGH closing more than 75% of the laryngotracheal airway. In agreement with our neonatologists and ear, nose and throat (ENT) specialists, we decided to begin oral propranolol therapy, which rapidly and dramatically improved respiratory symptoms. Fibrobronchoscopy six days after treatment confirmed a reduction of subglottic narrowing. Six months later the patient is doing well and without respiratory symptoms. To the best of our knowledge, this is the first reported case of the successful treatment with propranolol of an SGH obstructing more than 75% of the airway. The case is evidence of the effectiveness of oral propranolol as first-line treatment in the management of severely-obstructive paediatric SGH and the importance of CT and fibrobronchoscopy in the diagnosis; it also demonstrates the importance of multidisciplinary cooperation between thoracic surgeons, anaesthesiologists, neonatologists and ENT specialists in the treatment of these patients.
- 8 October 2012
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 43 (1) , 187-189
Open AccessPropranolol as first-line treatment of a severe subglottic haemangioma
Subglottic haemangioma (SGH) is a rare, benign tumour in children, which is potentially life-threatening because of airway obstruction. We report the case of a full-term 2-month-old infant girl admitted to our institution with stridor, dyspnoea and oxygen desaturation caused by a SGH and treated with propranolol. Neck-chest computed tomography (CT) revealed a contrast-enhancing, 10-mm, subglottic elliptic lesion, referable to SGH. Pre-treatment fibrobronchoscopy showed a sub-occlusive SGH closing more than 75% of the laryngotracheal airway. In agreement with our neonatologists and ear, nose and throat (ENT) specialists, we decided to begin oral propranolol therapy, which rapidly and dramatically improved respiratory symptoms. Fibrobronchoscopy six days after treatment confirmed a reduction of subglottic narrowing. Six months later the patient is doing well and without respiratory symptoms. To the best of our knowledge, this is the first reported case of the successful treatment with propranolol of an SGH obstructing more than 75% of the airway. The case is evidence of the effectiveness of oral propranolol as first-line treatment in the management of severely-obstructive paediatric SGH and the importance of CT and fibrobronchoscopy in the diagnosis; it also demonstrates the importance of multidisciplinary cooperation between thoracic surgeons, anaesthesiologists, neonatologists and ENT specialists in the treatment of these patients.
- 1 August 2012
- Published by Elsevier in Thoracic Surgery Clinics
- Vol. 22 (3) , 387-401
Pulmonary Infections of Surgical Interest in Childhood
- 1 August 2012
- Published by Elsevier in Thoracic Surgery Clinics
- Vol. 22 (3) , 387-401
Pulmonary Infections of Surgical Interest in Childhood
- 1 July 2011
- Published by SAGE Publications in The International Journal of Biological Markers
- Vol. 26 (3) , 160-165
Biomarkers in Malignant Mesothelioma: Diagnostic and Prognostic Role of Soluble Mesothelin-Related Peptide
Soluble mesothelin-related peptide (SMRP) is a biomarker that has been proposed for differential diagnosis from pleural metastatic cancer, as well as prognosis and treatment monitoring of malignant pleural mesothelioma (MM). The aim of this study was to evaluate the role of SMRP in clinic management of MM. We assayed the SMRP concentrations in 354 subjects: 109 healthy volunteers with no history of exposure to asbestos, 26 patients with previous occupational asbestos exposure but who were free from pleural or parenchymal disease, 48 patients with asbestosis, 110 patients with pleural plaques, 25 patients with lung cancer, and 36 patients with MM. We also tested SMRP titers in 2 patients with MM at 5 different times of the disease, to evaluate the trend of the biomarker in the course of therapy. Our data confirm previous experiences with the use of SMRP as a diagnostic marker of MM. Low SMRP levels at diagnosis seem to have a positive prognostic significance.
- 1 July 2011
- Published by SAGE Publications in The International Journal of Biological Markers
- Vol. 26 (3) , 160-165
Biomarkers in Malignant Mesothelioma: Diagnostic and Prognostic Role of Soluble Mesothelin-Related Peptide
Soluble mesothelin-related peptide (SMRP) is a biomarker that has been proposed for differential diagnosis from pleural metastatic cancer, as well as prognosis and treatment monitoring of malignant pleural mesothelioma (MM). The aim of this study was to evaluate the role of SMRP in clinic management of MM. We assayed the SMRP concentrations in 354 subjects: 109 healthy volunteers with no history of exposure to asbestos, 26 patients with previous occupational asbestos exposure but who were free from pleural or parenchymal disease, 48 patients with asbestosis, 110 patients with pleural plaques, 25 patients with lung cancer, and 36 patients with MM. We also tested SMRP titers in 2 patients with MM at 5 different times of the disease, to evaluate the trend of the biomarker in the course of therapy. Our data confirm previous experiences with the use of SMRP as a diagnostic marker of MM. Low SMRP levels at diagnosis seem to have a positive prognostic significance.
- 19 February 2011
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 18 (8) , 2251-2259
Does Mediastinal Extension of the Goiter Increase Morbidity of Total Thyroidectomy? A Multicenter Study of 19,662 Patients
Purpose To compare the outcome in patients with cervical goiters and cervicomediastinal goiters (CMGs) undergoing total thyroidectomy using the cervical or extracervical approach.
- 19 February 2011
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 18 (8) , 2251-2259
Does Mediastinal Extension of the Goiter Increase Morbidity of Total Thyroidectomy? A Multicenter Study of 19,662 Patients
Purpose To compare the outcome in patients with cervical goiters and cervicomediastinal goiters (CMGs) undergoing total thyroidectomy using the cervical or extracervical approach.
- Open Access
- 1 December 2009
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 9 (6) , 1035-1037
Surgical treatment of a rare case of tracheal inflammatory pseudotumor in pediatric age
Tracheal inflammatory pseudotumor (IPT) is a rare solid lesion with an unpredictable biological course. Treatment can vary and surgical resection may
- 1 December 2009
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 9 (6) , 1035-1037
Open AccessSurgical treatment of a rare case of tracheal inflammatory pseudotumor in pediatric age
Tracheal inflammatory pseudotumor (IPT) is a rare solid lesion with an unpredictable biological course. Treatment can vary and surgical resection may
- 2 March 2007
- Published by Wiley in Pediatric Pulmonology
- Vol. 42 (4) , 386-388
Catamenial hemoptysis from endobronchial endometriosis in a child with type 1 von Willebrand disease
Catamenial hemoptysis is a rare condition characterized by cyclic pulmonary hemorrhage, synchronous with menses and associated with the presence of intrapulmonary or endobronchial endometrial tissue. Because of the paucity of cases reported in the literature, information regarding the natural history is limited and also the optimal diagnostic workup and management of these patients are not well defined. In this report, we present a case of endobronchial endometriosis in a 12‐year‐old female diagnosed by bronchoscopy and immunocytochemical assay, associated with type 1 von Willebrand disease. Pediatr Pulmonol. 2007; 42:386–388.
- 2 March 2007
- Published by Wiley in Pediatric Pulmonology
- Vol. 42 (4) , 386-388
Catamenial hemoptysis from endobronchial endometriosis in a child with type 1 von Willebrand disease
Catamenial hemoptysis is a rare condition characterized by cyclic pulmonary hemorrhage, synchronous with menses and associated with the presence of intrapulmonary or endobronchial endometrial tissue. Because of the paucity of cases reported in the literature, information regarding the natural history is limited and also the optimal diagnostic workup and management of these patients are not well defined. In this report, we present a case of endobronchial endometriosis in a 12‐year‐old female diagnosed by bronchoscopy and immunocytochemical assay, associated with type 1 von Willebrand disease. Pediatr Pulmonol. 2007; 42:386–388.
- 1 January 2007
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 45 (5) , 634-8
Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results
Studies have suggested that soluble mesothelin-related protein (SMRP) can be used as a serum marker of malignant mesothelioma. We assessed the analytical performance of the Mesomark (Fujirebio Diagnostic) two-step ELISA on an automated analyser and performed a preliminary clinical evaluation. The precision of the assay and the in vitro effect of interfering substances on SMRP concentrations were investigated. The serum marker was analysed in 109 healthy subjects never exposed to asbestos, 26 healthy subjects exposed to asbestos, 33 patients with asbestosis, 33 with asbestos-related pleural plaques, 10 with non-malignant pleural diseases, 30 with lung cancer and 24 with histological diagnosis of pleural mesothelioma. Using the International Mesothelioma Interest Group classification, there were nine stage IV, two stage III, four stage II and nine stage I patients. SMRP concentrations of 4.75, 11.0 and 14 nmol/mL showed a total imprecision of 3.5%, 3.1% and 3.8%. The detection limit was 0.035 nmol/mL; the mean SMRP concentration of 0.63 nmol/mL was associated with a coefficient of variation of 10%. There was no effect (p>0.05) of interfering substances. Serum samples from patients with established pleural mesothelioma had significantly higher (p<0.05) concentrations of SMRP than control healthy and patient groups. SMRP measured on automated systems could be useful for the diagnosis of mesothelioma in routine clinical practice.
- 1 January 2007
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 45 (5) , 634-8
Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results
Studies have suggested that soluble mesothelin-related protein (SMRP) can be used as a serum marker of malignant mesothelioma. We assessed the analytical performance of the Mesomark (Fujirebio Diagnostic) two-step ELISA on an automated analyser and performed a preliminary clinical evaluation. The precision of the assay and the in vitro effect of interfering substances on SMRP concentrations were investigated. The serum marker was analysed in 109 healthy subjects never exposed to asbestos, 26 healthy subjects exposed to asbestos, 33 patients with asbestosis, 33 with asbestos-related pleural plaques, 10 with non-malignant pleural diseases, 30 with lung cancer and 24 with histological diagnosis of pleural mesothelioma. Using the International Mesothelioma Interest Group classification, there were nine stage IV, two stage III, four stage II and nine stage I patients. SMRP concentrations of 4.75, 11.0 and 14 nmol/mL showed a total imprecision of 3.5%, 3.1% and 3.8%. The detection limit was 0.035 nmol/mL; the mean SMRP concentration of 0.63 nmol/mL was associated with a coefficient of variation of 10%. There was no effect (p>0.05) of interfering substances. Serum samples from patients with established pleural mesothelioma had significantly higher (p<0.05) concentrations of SMRP than control healthy and patient groups. SMRP measured on automated systems could be useful for the diagnosis of mesothelioma in routine clinical practice.